Academic Thesis
|
|
Basic information
|
| Name | YASUI Kohichiroh |
| Belonging department | |
| Occupation name | |
| researchmap researcher code | 5000049673 |
| researchmap agency | Bukkyo University |
 |
Phase I/II study of first-line combination therapy with sorafenib plus resminostat
an oral HDAC inhibitor
versus sorafenib monotherapy for advanced hepatocellular carcinoma in east Asian patients.
|
|
Won Young Tak
Baek-Yeol Ryoo
Ho Yeong Lim
Do-Young Kim
Takuji Okusaka
Masafumi Ikeda
Hisashi Hidaka
Jong-Eun Yeon
Eishiro Mizukoshi
Manabu Morimoto
Myung-Ah Lee
Kohichiroh Yasui
Yasunori Kawaguchi
Jeong Heo
Sojiro Morita
Tae-You Kim
Junji Furuse
Kazuhiro Katayama
Takeshi Aramaki
Rina Hara
Takuya Kimura
Osamu Nakamura
Masatoshi Kudo
|
|
|
Investigational new drugs
|
|
|
|
|
|
2018/12
|
|
|
|
|
|
|
|
|
|
10.1007/s10637-018-0658-x
|
|
|
|
|
|
|
|
|
|
|
|